Hyperparathyroidism
📧 Sign up to get email alerts when something new happens for Hyperparathyroidism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-08-23Clinical Trial Update: Mineral and Bone Disorders Outcomes in Stage 5D of Chronic Kidney Disease
Completed update of a clinical trial evaluating mineral and bone disorders outcomes in Stage 5D chronic kidney disease (End-Stage Renal Dise…
-
CLINICAL_TRIALS trial_result · 2012-08-02Clinical Trial Update: Vitamin D Supplementation in HIV-infected Youth [Phase 2]
Phase 2 clinical trial evaluating Vitamin D (cholecalciferol) supplementation in HIV-infected youth with vitamin D deficiency has completed.
-
CLINICAL_TRIALS trial_result · 2012-07-03Clinical Trial Update: Coexisting Thyroid Disease and Hyperparathyroidism
This completed clinical trial investigated the coexistence of thyroid disease and hyperparathyroidism, with hyperthyroidism listed as the co…
-
CLINICAL_TRIALS trial_result · 2012-06-20Clinical Trial Update: Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D [Phase 4]
Phase 4 trial comparing paricalcitol to cinacalcet with low-dose vitamin D in patients with chronic kidney disease and secondary hyperparath…
-
CLINICAL_TRIALS trial_result · 2012-06-08Clinical Trial Update: Cinacalcet stUdy for Peritoneal Dialysis Patients In Double Arm on the Lowing Effect OF iPTH Level [Phase 4]
A Phase 4 trial evaluating cinacalcet in peritoneal dialysis patients with secondary hyperparathyroidism to lower iPTH levels has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-03-12Clinical Trial Update: Follow-up Patients With End Stage Renal Disease Receiving Zemplar to Prevent and Treat Secondary Hyperparathyroidism
A completed follow-up trial in end-stage renal disease patients treated with Zemplar (paricalcitol) to prevent and treat secondary hyperpara…
-
CLINICAL_TRIALS trial_result · 2012-02-07Clinical Trial Update: Prevention of Secondary Hyperparathyroidism With Vitamin D in Stage II/III Chronic Kidney Disease [NA]
Completed clinical trial evaluating whether vitamin D can prevent secondary hyperparathyroidism in patients with stage II/III chronic kidney…
-
CLINICAL_TRIALS trial_result · 2011-10-31Clinical Trial Update: Effectiveness and Safety of IV Zemplar in Patients on Hemodialysis and With Secondary Hyperparathyroidism Using iPTH/100 as Initial Dose [Phase 4]
Phase 4 trial evaluating the effectiveness and safety of intravenous Zemplar (paricalcitol) in patients on hemodialysis with secondary hyper…
-
CLINICAL_TRIALS trial_result · 2011-10-25Clinical Trial Update: Efficacy and Safety of 6 Months Treatment With Paricalcitol Injection or Oral in Patients With Secondary Hyperparathyroidism on Dialysis [Phase 4]
Phase 4 trial evaluating 6 months of paricalcitol injections or oral therapy for secondary hyperparathyroidism in dialysis patients; results…
-
CLINICAL_TRIALS trial_result · 2011-09-12Clinical Trial Update: Study of Zemplar iv in Patients With End Stage Chronic Kidney Disease, Undergoing Haemodialysis
A clinical trial evaluating intravenous paricalcitol (Zemplar IV) in patients with end-stage chronic kidney disease on haemodialysis for man…
-
CLINICAL_TRIALS trial_result · 2011-07-22Clinical Trial Update: Quality of Life in Patients Undergoing Parathyroidectomy
A completed clinical trial evaluating quality of life after parathyroidectomy in patients with hyperparathyroidism.
-
CLINICAL_TRIALS trial_result · 2011-07-13Clinical Trial Update: A Study of Cinacalcet to Improve Achievement of National Kidney Foundation Kidney Disease Outcomes Quality Initiative (K/DOQI) Targets in Patients With End Stage Renal Disease (ESRD) [Phase 4]
Phase 4 trial evaluating cinacalcet's ability to help end-stage renal disease patients meet K/DOQI targets for secondary hyperparathyroidism…
-
CLINICAL_TRIALS trial_result · 2011-06-17Clinical Trial Update: Paricalcitol Compared to Maxacalcitol in Chronic Kidney Disease Patients With Secondary Hyperparathyroidism [Phase 2]
Phase 2 trial comparing paricalcitol to maxacalcitol in chronic kidney disease patients with secondary hyperparathyroidism has completed and…
-
CLINICAL_TRIALS trial_result · 2011-04-27Clinical Trial Update: Evaluation of MRI and SPECT Fusion Software to Localize Parathyroid Adenomas
A terminated clinical trial evaluated MRI and SPECT fusion software to localize parathyroid adenomas. The study was sponsored by State Unive…
-
CLINICAL_TRIALS trial_result · 2011-04-19Clinical Trial Update: Long-term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Patients With Hemodialysis (HD) [Phase 2]
Phase 2 long-term safety study of paricalcitol injections in chronic kidney disease patients on hemodialysis has completed and results were …
-
CLINICAL_TRIALS trial_result · 2011-03-24Clinical Trial Update: Vitamin D Deficiency in Chronic Kidney Disease (CKD) Patients [Phase 4]
Phase 4 clinical trial update examining vitamin D deficiency in patients with chronic kidney disease and secondary hyperparathyroidism.
-
CLINICAL_TRIALS trial_result · 2011-03-01Clinical Trial Update: Study for Secondary Hyperparathyroidism in Chronic Renal Insufficiency Patients [Phase 2]
Phase 2 trial in chronic kidney disease patients with secondary hyperparathyroidism completed; results were posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-01-19Clinical Trial Update: Zemplar® Capsule in Reducing Serum Intact Parathyroid Hormone Levels in Chronic Kidney Disease Stage 5 Subjects on Hemodialysis or Peritoneal Dialysis [Phase 3]
Phase 3 trial update indicating completion of a study evaluating Zemplar Capsule (paricalcitol) for reducing serum intact parathyroid hormon…
-
CLINICAL_TRIALS trial_result · 2010-10-27Clinical Trial Update: ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis [Phase 4]
A Phase 4 study evaluated whether cinacalcet plus low-dose vitamin D affects vascular calcification in adults with chronic kidney disease on…
-
CLINICAL_TRIALS trial_result · 2010-08-18Clinical Trial Update: Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyroidism in Calcitriol Resistant Dialysis Subjects [Phase 4]
Phase 4 trial evaluating paricalcitol for calcitriol-resistant secondary hyperparathyroidism in dialysis patients was terminated, with resul…
-
CLINICAL_TRIALS trial_result · 2010-05-04Clinical Trial Update: Efficacy and Safety of Alfacalcidol Compared to Calcitriol for Treatment of Secondary Hyperparathyroidism [Phase 4]
This Phase 4 trial compares alfacalcidol to calcitriol for efficacy and safety in treating secondary hyperparathyroidism in patients with en…
-
CLINICAL_TRIALS trial_result · 2010-04-23Clinical Trial Update: Treatment for Patients With Secondary Hyperparathyroidism of End-Stage Renal Disease (ESRD) [Phase 2]
Phase 2 clinical trial evaluating treatment for secondary hyperparathyroidism in end-stage renal disease has completed.
-
CLINICAL_TRIALS trial_result · 2010-04-02Clinical Trial Update: Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patients Receiving Hemodialysis [Phase 2]
Phase 2 dose-response study evaluating paricalcitol injection in chronic kidney disease patients on hemodialysis with secondary hyperparathy…
-
CLINICAL_TRIALS trial_result · 2010-01-27Clinical Trial Update: Effects of Parathyroidectomy on Cardiovascular Risk Factors in Primary Hyperparathyroidism
This clinical trial analyzes how parathyroidectomy affects cardiovascular risk factors in patients with primary hyperparathyroidism. The stu…
-
CLINICAL_TRIALS trial_result · 2010-01-05Clinical Trial Update: Oral Peptones Load in Normocalcemic and Hypercalcemic Primary Hyperparathyroidism and Healthy Subjects [NA]
A completed clinical trial evaluating oral peptone loading in adults with primary hyperparathyroidism and hypercalcemia, as well as healthy …